37 participants
Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-12
- Start Date:
- 2024-12-26
- Completion:
- 2027-08-31
Conditions
- Low Grade Ovarian Serous Adenocarcinoma
Interventions
- DRUG
No Results Yet